Skip to main content
logo
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.070
+0.010 (0.25%)
At close: Jun 18, 2026, 4:00 PM EDT
4.084
+0.014 (0.34%)
After-hours: Jun 18, 2026, 6:50 PM EDT

Opus Genetics Revenue

Opus Genetics had revenue of $2.16M in the quarter ending March 31, 2026, a decrease of -50.64%. This brings the company's revenue in the last twelve months to $11.98M, down -12.22% year-over-year. In the year 2025, Opus Genetics had annual revenue of $14.20M with 29.15% growth.

Revenue (ttm)
$11.98M
Revenue Growth
-12.22%
P/S Ratio
27.65
Revenue / Employee
$427,964
Employees
28
Market Cap
331.28M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.20M3.20M29.15%
Dec 31, 202410.99M-8.06M-42.30%
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 200875.00K--
Dec 31, 200775.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals217.78M
OmniAb28.94M
Abeona Therapeutics14.54M
Upstream Bio3.32M
Silence Therapeutics839.00K
Revenue Rankings

IRD News

More News